Katherine E. Hanlon, Ph.D.

Affiliations: 
2012 Medical Pharmacology University of Arizona, Tucson, AZ 
Area:
Pain, opioids, pharmacology
Google:
"Katherine Hanlon"
Mean distance: 17.73 (cluster 32)
 
SNBCP

Parents

Sign in to add mentor
Todd W. Vanderah grad student 2012 University of Arizona
 (Cannabinoid receptor 2: A novel multi-targeted approach in the treatment of breast cancer and related skeletal metastasis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hanlon KE, Lozano-Ondoua AN, Umaretiya PJ, et al. (2016) Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. Breast Cancer (Dove Medical Press). 8: 59-71
Largent-Milnes TM, Brookshire SW, Skinner DP, et al. (2013) Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. The Journal of Pharmacology and Experimental Therapeutics. 347: 7-19
Lozano-Ondoua AN, Hanlon KE, Symons-Liguori AM, et al. (2013) Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 92-107
Hanlon KE, Herman DS, Agnes RS, et al. (2011) Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain. Brain Research. 1395: 1-11
Lee YS, Kulkarani V, Cowell SM, et al. (2011) Development of potent μ and δ opioid agonists with high lipophilicity. Journal of Medicinal Chemistry. 54: 382-6
Hanlon KE, Vanderah TW. (2010) Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses. Methods in Enzymology. 484: 3-30
Hanlon K, Rudin CE, Harries LW. (2009) Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). Plos One. 4: e7169
Hanlon K, Harries LW, Ellard S, et al. (2009) Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology. The Journal of Molecular Diagnostics : Jmd. 11: 450-7
Hanlon K, Ellard S, Rudin CE, et al. (2009) Evaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques. The Journal of Molecular Diagnostics : Jmd. 11: 298-305
Lippert E, Girodon F, Hammond E, et al. (2009) Concordance of assays designed for the quantification of JAK2V617F: A multicenter study Haematologica. 94: 38-45
See more...